Anger HO. Scintillation camera. Rev Sci Instrum. 1958;29:27–33.

CAS  Google Scholar 

Cassen B, Curtis L, Reed C, Libby R. Instrumentation for I-131 use in medical studies. Nucleonics. 1951;9:46–50.

Google Scholar 

Tollefson J. Reactor shutdown threatens world’s medical-isotope supply. Nature. 2016;12.

Rivard MJ, Bobek LM, Butler RA, Garland MA, Hill DJ, Krieger JK, et al. The US national isotope program: current status and strategy for future success. Appl Radiat Isot. 2005;63:157–78.

CAS  PubMed  Google Scholar 

Sasaki Y. Nuclear oncology as seen by me in Japan: a historical review and future perspective. Ann Nucl Med. 2020;34:1–12.

CAS  PubMed  Google Scholar 

Baidoo KE, Yong K, Brechbiel MW. Molecular pathways: targeted α-particle radiation therapy. Clin Cancer Res. 2013;19:530–7.

CAS  PubMed  Google Scholar 

Poty S, Francesconi LC, McDevitt MR, Morris MJ, Lewis JS. α-emitters for radiotherapy: from basic radiochemistry to clinical studies—part 2. J Nucl Med. 2018;59:1020–7.

CAS  PubMed  PubMed Central  Google Scholar 

Scheinberg A. R McDevitt M. Actinium-225 in targeted alpha-particle therapeutic applications. Curr Radiopharm. 2011;4:306–20.

CAS  PubMed  PubMed Central  Google Scholar 

McDevitt MR, Finn RD, Ma D, Larson SM, Scheinberg DA. Preparation of α-emitting 213Bi-labeled antibody constructs for clinical use. J Nucl Med. 1999;40:1722–7.

CAS  PubMed  Google Scholar 

Nilsson S, Larsen RH, Fosså SD, Balteskard L, Borch KW, Westlin J-E, et al. First clinical experience with α-emitting radium-223 in the treatment of skeletal metastases. Clin Cancer Res. 2005;11:4451–9.

CAS  PubMed  Google Scholar 

García-Toraño E, Medina VP, Romero E, Roteta M. Measurement of the half-life of 68Ga. Appl Radiat Isot. 2014;87:122–5.

PubMed  Google Scholar 

Lepareur N. Cold kit labeling: the future of 68Ga radiopharmaceuticals? Front Med. 2022;9:812050.

Google Scholar 

Mettler F, Guiberteau M. Radioactivity, radionuclides, and radiopharmaceuticals. Essentials of nuclear medicine and molecular imaging. Philadelphia: Elsevier; 2019.

Google Scholar 

Forgacs P. The gallium scan and inflammatory lesions. Arch Intern Med. 1982;142:231.

CAS  PubMed  Google Scholar 

Zuckier LS, Valdivia AY, Zamora E. Does gallium-citrate have yet another story to tell? Lessons relevant to the COVID-19 era. Eur J Nucl Med Mol Imaging. 2020;47:2059–61.

CAS  PubMed  PubMed Central  Google Scholar 

George K, Borjian S, Cross M, Hicks J, Schaffer P, Kovacs M. Expanding the PET radioisotope universe utilizing solid targets on small medical cyclotrons. RSC Adv. 2021;11:31098–123.

CAS  PubMed  PubMed Central  Google Scholar 

Rinne SS, Abouzayed A, Gagnon K, Tolmachev V, Orlova A. 66Ga-PET-imaging of GRPR-expression in prostate caproductionuction and characterization of [66Ga] Ga-NOTA-PEG2-RM26. Sci Rep. 2021;11:3631.

CAS  PubMed  PubMed Central  Google Scholar 

Kossert K, Schrader H. Activity standardization by liquid scintillation counting and half-life measurements of 90Y. Appl Radiat Isot. 2004;60:741–9.

CAS  PubMed  Google Scholar 

Yoo J, Tang L, Perkins TA, Rowland DJ, Laforest R, Lewis JS, et al. Preparation of high specific activity 86Y using a small biomedical cyclotron. Nucl Med Biol. 2005;32:891–7.

CAS  PubMed  Google Scholar 

Braad P, Hansen S, Thisgaard H, Høilund-Carlsen P. PET imaging with the non-pure positron emitters: 55Co, 86Y and 124I. Phys Med Biol. 2015;60:3479.

CAS  PubMed  Google Scholar 

Dash A, Pillai MRA, Knapp FF. Production of 177Lu for targeted radionuclide therapy: available options. Nucl Med Mol Imaging (2010). 2015;49:85–107.

de Aguiar Ferreira C, Fuscaldi LL, Townsend DM, Rubello D, de Barros ALB. Radiolabeled bombesin derivatives for preclinical oncological imaging. Biomed Pharmacother. 2017;87:58–72.

Google Scholar 

Hong JH. An update of prostate-specific membrane antigen theranostics in prostate cancer. Korean J Urol Oncol. 2022;20:207–22.

Google Scholar 

Pommé S, Marouli M, Suliman G, Dikmen H, Van Ammel R, Jobbágy V, et al. Measurement of the 225Ac half-life. Appl Radiat Isot. 2012;70:2608–14.

PubMed  Google Scholar 

Hassan M, Bokhari TH, Lodhi NA, Khosa MK, Usman M. A review of recent advancements in Actinium-225 labeled compounds and biomolecules for therapeutic purposes. Chem Biol Drug Des. 2023;102:1276–92.

CAS  PubMed  Google Scholar 

Rahman AR, Babu MH, Ovi MK, Zilani MM, Eithu IS, Chakraborty A. Actinium-225 in targeted alpha therapy. J Med Phys. 2024;49:137–47.

PubMed  PubMed Central  Google Scholar 

Jurisson SS, Lydon JD. Potential technetium small molecule radiopharmaceuticals. Chem Rev. 1999;99:2205–18.

CAS  PubMed  Google Scholar 

Green CH. Technetium-99m production issues in the United Kingdom. J Med Phys. 2012;37:66–71.

PubMed  PubMed Central  Google Scholar 

Wenzl M, Colombo F, Guanais F, Lopert R, Paris V, Pearson M, et al. The supply of Medical isotopes: an economic diagnosis and possible solutions. OECD; 2019.

Lederer CM, Hollander JM, Perlman I, Segrè EG. Table of isotopes. Phys Today. 1967;20:97–9.

Google Scholar 

Parker C, Heidenreich A, Nilsson S, Shore N. Current approaches to incorporation of radium-223 in clinical practice. Prostate Cancer Prostatic Dis. 2018;21:37–47.

CAS  PubMed  PubMed Central  Google Scholar 

Abou DS, Ulmert D, Doucet M, Hobbs RF, Riddle RC, Thorek DL. Whole-body and microenvironmental localization of radium-223 in naive and mouse models of prostate cancer metastasis. J Natl Cancer Inst. 2016;108:djv380.

PubMed  Google Scholar 

Basch E, Loblaw DA, Oliver TK, Carducci M, Chen RC, Frame JN, et al. Systemic therapy in men with metastatic castration-resistant prostate cancer: American Society of Clinical Oncology and Cancer Care Ontario clinical practice guideline. J Clin Oncol. 2014;32:3436–48.

CAS  PubMed  PubMed Central  Google Scholar 

Ahenkorah S, Cassells I, Deroose CM, Cardinaels T, Burgoyne AR, Bormans G, et al. Bismuth-213 for targeted radionuclide therapy: from atom to bedside. Pharmaceutics. 2021;13:599.

CAS  PubMed  PubMed Central  Google Scholar 

Franchi S, Di Marco V, Tosato M. Bismuth chelation for targeted alpha therapy: current state of the art. Nucl Med Biol. 2022;114:168–88.

PubMed  Google Scholar 

Knapp FF, Dash A. Radiopharmaceuticals for therapy. Springer; 2016.

Jurcic JG, Larson SM, Sgouros G, McDevitt MR, Finn RD, Divgi CR, et al. Targeted α particle immunotherapy for myeloid leukemia. Blood. 2002;100:1233–9.

CAS  PubMed  Google Scholar 

Allen BJ, Raja C, Rizvi S, Li Y, Tsui W, Graham P, et al. Intralesional targeted alpha therapy for metastatic melanoma. Cancer Biol Ther. 2005;4:1318–24.

CAS  PubMed  Google Scholar 

Chan HS, De Blois E, Morgenstern A, Bruchertseifer F, De Jong M, Breeman W, et al. In Vitro comparison of 213Bi-and 177Lu-radiation for peptide receptor radionuclide therapy. PLoS ONE. 2017;12:e0181473.

PubMed  PubMed Central  Google Scholar 

Gustafsson-Lutz A, Bäck T, Aneheim E, Hultborn R, Palm S, Jacobsson L, et al. Therapeutic efficacy of α-radioimmunotherapy with different activity levels of the 213Bi-labeled monoclonal antibody MX35 in an ovarian cancer model. EJNMMI Res. 2017;7:1–8.

CAS  Google Scholar 

Fichou N, Gouard S, Maurel C, Barbet J, Ferrer L, Morgenstern A, et al. Single-dose anti-CD138 radioimmunotherapy: bismuth-213 is more efficient than lutetium-177 for treatment of multiple myeloma in a preclinical model. Front Med. 2015;2:76.

Google Scholar 

Królicki L, Bruchertseifer F, Kunikowska J, Koziara H, Królicki B, Jakuciński M, et al. Safety and efficacy of targeted alpha therapy with 213Bi-DOTA-substance P in recurrent glioblastoma. Eur J Nucl Med Mol Imaging. 2019;46:614–22.

PubMed  Google Scholar 

Holland JP, Ferdani R, Anderson CJ, Lewis JS. Copper-64 radiopharmaceuticals for oncologic imaging. PET Clin. 2009;4:49–67.

PubMed  PubMed Central  Google Scholar 

Nedrow JR, White AG, Modi J, Nguyen K, Chang AJ, Anderson CJ. Positron emission tomographic imaging of copper 64–and gallium 68–labeled chelator conjugates of the somatostatin agonist Tyr3-octreotate. Mol Imaging. 2014;13:1–13.

Google Scholar 

Braune A, Oehme L, Freudenberg R, Hofheinz F, van den Hoff J, Kotzerke J, et al. Comparison of image quality and spatial resolution between 18F, 68Ga, and 64Cu phantom measurements using a digital Biograph Vision PET/CT. EJNMMI Phys. 2022;9:58.

PubMed  PubMed Central